Oxazinanes
Aobchem 6-Bromo-4-fluoro-2-methyl-2H-indazole | ≥97% | CAS 2092036-32-1 | C8H6BrFN2 | 1g
6-Bromo-4-fluoro-2-methyl-2H-indazole | ≥97% | CAS 2092036-32-1 | C8H6BrFN2 | 1g
Aobchem 6-Bromo-4-fluoro-2-methyl-2H-indazole | ≥97% | CAS 2092036-32-1 | C8H6BrFN2 | 250mg
6-Bromo-4-fluoro-2-methyl-2H-indazole | ≥97% | CAS 2092036-32-1 | C8H6BrFN2 | 250mg
Aobchem 7-Bromo-4-fluoro-2-methyl-2H-indazole | ≥97% | CAS 1780711-14-9 | C8H6BrFN2 | 1g
7-Bromo-4-fluoro-2-methyl-2H-indazole | ≥97% | CAS 1780711-14-9 | C8H6BrFN2 | 1g
Aobchem (2 5-Dichlorophenyl)(morpholino)methanone | 97% | CAS 136065-10-6 | C11H11Cl2NO2 | 5g
(2 5-Dichlorophenyl)(morpholino)methanone | 97% | CAS 136065-10-6 | C11H11Cl2NO2 | 5g
Aobchem 5-Bromo-2 7-naphthyridin-1(2H)-one | 95% | CAS 1260663-94-2 | C8H5BrN2O | 250mg
5-Bromo-2 7-naphthyridin-1(2H)-one | 95% | CAS 1260663-94-2 | C8H5BrN2O | 250mg
Aobchem (3 5-Dimethylphenyl)(morpholino)methanone | 95% | CAS 203448-40-2 | C13H17NO2 | 5g
(3 5-Dimethylphenyl)(morpholino)methanone | 95% | CAS 203448-40-2 | C13H17NO2 | 5g
Aobchem 1-(4-Benzoylphenyl)ethanone | 95% | CAS 53689-84-2 | C15H12O2 | 1g
1-(4-Benzoylphenyl)ethanone | 95% | CAS 53689-84-2 | C15H12O2 | 1g
Aobchem (3 5-Dimethylphenyl)(morpholino)methanone | 95% | CAS 203448-40-2 | C13H17NO2 | 1g
(3 5-Dimethylphenyl)(morpholino)methanone | 95% | CAS 203448-40-2 | C13H17NO2 | 1g
Aobchem 1-(3-Chloro-5-morpholinophenyl)propan-1-one | 95% | C13H16ClNO2 | 1g
1-(3-Chloro-5-morpholinophenyl)propan-1-one | 95% | C13H16ClNO2 | 1g
Aobchem (5-Ethylbenzofuran-2-yl)boronic acid | 97% | CAS 1450790-30-3 | C10H11BO3 | 1g
(5-Ethylbenzofuran-2-yl)boronic acid | 97% | CAS 1450790-30-3 | C10H11BO3 | 1g
Cayman Chemical Dimebolin (hydrochloride), Purity: ≥98%, CAS: 97657-92-6, 1 mg
A neuroprotective agent; binds to histamine H1 and H2 receptors (IC50s = 3.8 and 287 nM, respectively), as well as α1A-, α1B-, α1D-, and α2A-ARs, imidazoline I2 receptors, and 5-HT2A, 5-HT2C, 5-HT6, and 5-HT7 receptors (Kis = 8-313 nM); inhibits NMDA-evoked currents and voltage-gated calcium channels in mouse primary striatal neurons (IC50s = 10 and 50 μM, respectively); inhibits glutamate-induced apoptosis in primary striatal neurons derived from the YAC128 transgenic mouse model of Huntington’s disease at 50 μM; inhibits cell death induced by amyloid-β (25-35) in cerebellar granule cells at 25 μM; inhibits decreases TWAA acquisition in a rat model of AF64A-induced Alzheimer’s disease at 1 mg/kg
Cayman Chemical Dimebolin (hydrochloride), Purity: ≥98%, CAS: 97657-92-6, 10 mg
A neuroprotective agent; binds to histamine H1 and H2 receptors (IC50s = 3.8 and 287 nM, respectively), as well as α1A-, α1B-, α1D-, and α2A-ARs, imidazoline I2 receptors, and 5-HT2A, 5-HT2C, 5-HT6, and 5-HT7 receptors (Kis = 8-313 nM); inhibits NMDA-evoked currents and voltage-gated calcium channels in mouse primary striatal neurons (IC50s = 10 and 50 μM, respectively); inhibits glutamate-induced apoptosis in primary striatal neurons derived from the YAC128 transgenic mouse model of Huntington’s disease at 50 μM; inhibits cell death induced by amyloid-β (25-35) in cerebellar granule cells at 25 μM; inhibits decreases TWAA acquisition in a rat model of AF64A-induced Alzheimer’s disease at 1 mg/kg
Cayman Chemical PIK-75, Purity: ≥98%, CAS: 372196-67-3, 5 mg
A selective inhibitor of p110α with an IC50 value of 5.8 nM; inhibits p110γ and p110β with IC50 values of 0.076 µM and 1.3 µM, respectively
Aobchem 4 5-Dibromo-2-methyl-2H-1 2 3-triazole | ≥95% | CAS 28938-17-2 | C3H3Br2N3 | 5g
4 5-Dibromo-2-methyl-2H-1 2 3-triazole | ≥95% | CAS 28938-17-2 | C3H3Br2N3 | 5g
Aobchem 1-Methyl-2-(4-nitrophenoxy)benzene | 97% | CAS 2444-29-3 | C13H11NO3 | 5g
1-Methyl-2-(4-nitrophenoxy)benzene | 97% | CAS 2444-29-3 | C13H11NO3 | 5g